Cantor Fitzgerald’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.6M Sell
800,000
-425,000
-35% -$10M 0.25% 60
2025
Q4
$39.8M Buy
1,225,000
+334,900
+38% +$14.3M 0.6% 46
2025
Q3
$50.5M Buy
+890,100
New +$45.6M 0.49% 41
2025
Q2
Sell
-20,000
Closed -$591K 489
2025
Q1
$591K Buy
+20,000
New +$743K 0.01% 140

Other funds holding HIMS

Cantor Fitzgerald's HIMS Position: Q1 2026 in Review

Cantor Fitzgerald reduced its Hims & Hers Health (HIMS) stake by 25% in Q1 2026, selling an estimated $8.55M and leaving 1,089,620 shares worth $22.6M. The position accounts for 0.33% of the portfolio, ranked #53.

Cantor Fitzgerald first reported a position in HIMS in Q3 2023 and has held it in 6 quarters since. The position peaked at $48.7M in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Cantor Fitzgerald held 1,089,620 shares of Hims & Hers Health worth $22.6M as of Q1 2026.
  • Cantor Fitzgerald sold 361,826 Hims & Hers Health shares in Q1 2026, an estimated $8.55M.
  • Hims & Hers Health made up 0.33% of Cantor Fitzgerald's portfolio in Q1 2026, its #53 holding.
  • Cantor Fitzgerald first reported a position in Hims & Hers Health in Q3 2023 and has held it in 6 quarters since.
  • Cantor Fitzgerald's Hims & Hers Health position peaked at $48.7M in Q3 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Cantor Fitzgerald's 13F filing for Q1 2026, filed 15 May 2026.